Modulation of Alpha 1 Adrenergic Receptors on Urinary Bladder in Rat Spinal Cord Injury Model

Overview

Journal Int Neurourol J

Date 2012 Jul 21

PMID 22816046

Citations 6

Authors

Gilho Lee

Heeyoon Park

Hong Suk Park

Jeong Gu Lee

Affiliations

Soon will be listed here.

Abstract

Purpose: Whereas many studies have focused on the vesical changes of the α1 adrenergic receptor (AR) subtypes in partial outlet obstruction, few studies have addressed the modulation of the α1 AR subtypes after spinal cord injury (SCI). Therefore, we studied the modulation of the α1 ARs in urinary bladder in a rat SCI model.

Methods: Four weeks after a SCI, the whole vesical bodies from eight female Sprague-Dawley rats and from eight controls were harvested. The total RNA was extracted from the samples and was used to prepare cDNA. We developed standard plasmid constructs of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and three α1 ARs (α1a, α1b, and α1d) to convert the cycle threshold (Ct) values from real-time polymerase chain reaction (RT-PCR) into subtype mRNA concentrations. The detected Ct values of 16 samples from RT-PCR were interpolated into the standard plasmid curves.

Results: All serially diluted standard samples showed very good linearity. The mRNA expression of GAPDH was higher in the SCI group, whereas the mRNA expression of all α1 ARs was lower in the SCI group than in the control animals. The α1a, α1b, and α1d mRNA expression in the controls was 81.7%, 3.3%, and 15.1%, respectively, whereas the α1a, α1b, and α1d mRNA expression in the SCI group was 33.5%, 5.2%, and 60.9%, respectively.

Conclusions: SCI moderates the α1 AR mRNA subtypes in the urinary bladder. The relatively increased α1d or decreased α1a AR mRNA expression may be a therapeutic candidate for controlling the symptoms of neurogenic bladder after SCI.

Citing Articles

Expression and localization of α-adrenergic receptor in the rat post-natal developing cochlea.

Tian C, Yang Y, Li Y, Sun F, Qu J, Zha D Eur J Histochem. 2023; 67(3).

PMID: 37548252 PMC: 10476538. DOI: 10.4081/ejh.2023.3748.

Molecular Mechanism Operating in Animal Models of Neurogenic Detrusor Overactivity: A Systematic Review Focusing on Bladder Dysfunction of Neurogenic Origin.

Ferreira A, Nascimento D, Cruz C Int J Mol Sci. 2023; 24(4).

PMID: 36834694 PMC: 9959149. DOI: 10.3390/ijms24043273.

Effects of an alpha-1d adrenoreceptor antagonist (naftopidil) on bladder dysfunction after radiotherapy in female rats.

Lee S, Kim H, Lee D Int Urogynecol J. 2020; 32(10):2747-2755.

PMID: 32761376 DOI: 10.1007/s00192-020-04472-5.

Recommendations for evaluation of bladder and bowel function in pre-clinical spinal cord injury research.

Holmes G, Hubscher C, Krassioukov A, Jakeman L, Kleitman N J Spinal Cord Med. 2019; 43(2):165-176.

PMID: 31556844 PMC: 7054945. DOI: 10.1080/10790268.2019.1661697.

Spinal α -adrenoceptors and neuropathic pain modulation; therapeutic target.

Bahari Z, Meftahi G Br J Pharmacol. 2019; 176(14):2366-2381.

PMID: 30657594 PMC: 6592871. DOI: 10.1111/bph.14580.

References

Bustin S . Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol. 2000; 25(2):169-93. DOI: 10.1677/jme.0.0250169. View

Valentino R, Wood S, Wein A, Zderic S . The bladder-brain connection: putative role of corticotropin-releasing factor. Nat Rev Urol. 2010; 8(1):19-28. PMC: 3662807. DOI: 10.1038/nrurol.2010.203. View

Wang J, Liu C, Tsai S, Wei C, Chin T . Augmentation cystoplasty and simultaneous ureteral reimplantation reduce high-grade vesicoureteral reflux in children with neurogenic bladder. J Chin Med Assoc. 2011; 74(7):294-7. DOI: 10.1016/j.jcma.2011.05.004. View

Kurizaki Y, Ishizuka O, Imamura T, Ichino M, Ogawa T, Igawa Y . Relation between expression of α(1)-adrenoceptor mRNAs in bladder mucosa and urodynamic findings in men with lower urinary tract symptoms. Scand J Urol Nephrol. 2010; 45(1):15-9. DOI: 10.3109/00365599.2010.515611. View

Arai K, Tanoue A, Goda N, Takeda M, Takahashi K, Tsujimoto G . Characterization of the mouse alpha1D-adrenergic receptor gene. Jpn J Pharmacol. 2000; 81(3):271-8. DOI: 10.1254/jjp.81.271. View

Yamada S, Ohkura T, Deguchi Y, Kimura R . In vivo measurement by [3H]Tamsulosin of alpha1 adrenoceptors in rat tissues in relation to the pharmacokinetics. J Pharmacol Exp Ther. 1999; 289(3):1575-83. View

Mahfouz W, Corcos J . Management of detrusor external sphincter dyssynergia in neurogenic bladder. Eur J Phys Rehabil Med. 2011; 47(4):639-50. View

Barendrecht M, Frazier E, Vrydag W, Alewijnse A, Peters S, Michel M . The effect of bladder outlet obstruction on alpha1- and beta-adrenoceptor expression and function. Neurourol Urodyn. 2008; 28(4):349-55. DOI: 10.1002/nau.20642. View

Forray , Noble . Subtype selective alpha1-adrenoceptor antagonists for the treatment of benign prostatic hyperplasia. Expert Opin Investig Drugs. 2001; 8(12):2073-2094. DOI: 10.1517/13543784.8.12.2073. View

10.

Malloy B, Price D, Price R, Bienstock A, Dole M, Funk B . Alpha1-adrenergic receptor subtypes in human detrusor. J Urol. 1998; 160(3 Pt 1):937-43. DOI: 10.1016/S0022-5347(01)62836-2. View

11.

Beckel J, Holstege G . Neuroanatomy of the lower urinary tract. Handb Exp Pharmacol. 2011; (202):99-116. DOI: 10.1007/978-3-642-16499-6_6. View

12.

Takahashi S, Tajima A, Matsushima H, Kawamura T, Tominaga T, Kitamura T . Clinical efficacy of an alpha1A/D-adrenoceptor blocker (naftopidil) on overactive bladder symptoms in patients with benign prostatic hyperplasia. Int J Urol. 2006; 13(1):15-20. DOI: 10.1111/j.1442-2042.2006.01222.x. View

13.

Saito M, Longhurst P, Tammela T, Wein A, Levin R . Effects of partial outlet obstruction of the rat urinary bladder on micturition characteristics, DNA synthesis and the contractile response to field stimulation and pharmacological agents. J Urol. 1993; 150(3):1045-51. DOI: 10.1016/s0022-5347(17)35683-5. View

14.

Colell A, Green D, Ricci J . Novel roles for GAPDH in cell death and carcinogenesis. Cell Death Differ. 2009; 16(12):1573-81. DOI: 10.1038/cdd.2009.137. View

15.

Kojima Y, Sasaki S, Kubota Y, Imura M, Oda N, Kiniwa M . Up-regulation of α1a and α1d-adrenoceptors in the prostate by administration of subtype selective α1-adrenoceptor antagonist tamsulosin in patients with benign prostatic hyperplasia. J Urol. 2011; 186(4):1530-6. DOI: 10.1016/j.juro.2011.05.048. View

16.

Rank M, Murray K, Stephens M, DAmico J, Gorassini M, Bennett D . Adrenergic receptors modulate motoneuron excitability, sensory synaptic transmission and muscle spasms after chronic spinal cord injury. J Neurophysiol. 2010; 105(1):410-22. PMC: 3023364. DOI: 10.1152/jn.00775.2010. View

17.

Tator C, Duncan E, Edmonds V, Lapczak L, ANDREWS D . Changes in epidemiology of acute spinal cord injury from 1947 to 1981. Surg Neurol. 1993; 40(3):207-15. DOI: 10.1016/0090-3019(93)90069-d. View

18.

Ford A, Daniels D, Chang D, Gever J, Jasper J, Lesnick J . Pharmacological pleiotropism of the human recombinant alpha1A-adrenoceptor: implications for alpha1-adrenoceptor classification. Br J Pharmacol. 1997; 121(6):1127-35. PMC: 1564783. DOI: 10.1038/sj.bjp.0701207. View

19.

Kojima Y, Sasaki S, Imura M, Kubota Y, Hayashi Y, Kohri K . Correlation between expression of α₁-adrenoceptor subtype mRNA and severity of lower urinary tract symptoms or bladder outlet obstruction in benign prostatic hyperplasia patients. BJU Int. 2010; 107(3):438-42. DOI: 10.1111/j.1464-410X.2010.09596.x. View

20.

Malkowicz S, Wein A, Elbadawi A, Van Arsdalen K, Ruggieri M, Levin R . Acute biochemical and functional alterations in the partially obstructed rabbit urinary bladder. J Urol. 1986; 136(6):1324-9. DOI: 10.1016/s0022-5347(17)45331-6. View